Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Rudick

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
AJNR. American Journal of Neuroradiology|July 1, 1987
Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imagingJ H Simon, R B Schiffer, R A Rudick, et al.
Transactions of the American Neurological Association|January 1, 1980
Recovery from the locked-in syndromeE A McCusker, R A Rudick, G W Honch, et al.
Journal of Neuroimmunology|April 1, 1992
Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivoR M Ransohoff, V K Tuohy, B P Barna, et al.
Archives of Neurology|December 1, 1990
Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imagingM L Estes, R A Rudick, G H Barnett, et al.
Archives of Neurology|June 1, 1986
Multiple sclerosis. The problem of incorrect diagnosisR A Rudick, R B Schiffer, K M Schwetz, et al.
Journal of Clinical Laboratory Analysis|January 1, 1991
Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluidG L Stanescu, A R Swick, V K Tuohy, et al.
Archives of Neurology|November 1, 1988
Pulmonary function and dysfunction in multiple sclerosisS C Smeltzer, M J Utell, R A Rudick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 1999
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task ForceJ S Fischer, R A Rudick, G R Cutter, et al.
Neurology|November 24, 1999
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research GroupR A Rudick, E Fisher, J C Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 1995
Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chainsR A Rudick, S V Medendorp, M Namey, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
AJNR. American Journal of Neuroradiology|July 1, 1987
Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imagingJ H Simon, R B Schiffer, R A Rudick, et al.
Transactions of the American Neurological Association|January 1, 1980
Recovery from the locked-in syndromeE A McCusker, R A Rudick, G W Honch, et al.
Journal of Neuroimmunology|April 1, 1992
Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivoR M Ransohoff, V K Tuohy, B P Barna, et al.
Archives of Neurology|December 1, 1990
Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imagingM L Estes, R A Rudick, G H Barnett, et al.
Archives of Neurology|June 1, 1986
Multiple sclerosis. The problem of incorrect diagnosisR A Rudick, R B Schiffer, K M Schwetz, et al.
Journal of Clinical Laboratory Analysis|January 1, 1991
Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluidG L Stanescu, A R Swick, V K Tuohy, et al.
Archives of Neurology|November 1, 1988
Pulmonary function and dysfunction in multiple sclerosisS C Smeltzer, M J Utell, R A Rudick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 1999
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task ForceJ S Fischer, R A Rudick, G R Cutter, et al.
Neurology|November 24, 1999
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research GroupR A Rudick, E Fisher, J C Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 1995
Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chainsR A Rudick, S V Medendorp, M Namey, et al.
Pageof 13